| Literature DB >> 35499928 |
Corinna Gartner1, Andreas Bickl2, Sabine Härtl1, Johanna K Loy2, Laura Häffner1.
Abstract
Background and aim: A wide range of studies indicates that men and women with Problem (PrG) and Pathological Gambling (PG) differ in several clinical and sociodemographic characteristics. However, evidence for sex differences, such as the telescoping effect, is contradictory, and it is still unclear whether sex differences observed in offline gambling can also be found for online gambling. Furthermore, reviews have so far focused on binary sex differences but neglect gender aspects. In this study, an updated literature survey of sex- and gender-related differences in PrG and PG was conducted.Entities:
Keywords: pathological gambling; problem gambling; review; sex and gender differences
Year: 2022 PMID: 35499928 PMCID: PMC9295224 DOI: 10.1556/2006.2022.00019
Source DB: PubMed Journal: J Behav Addict ISSN: 2062-5871 Impact factor: 7.772
126 papers for the literature survey
| Study | Country | Sample Size | Sex (%) | Mean age (SD, age range) | Sample type | Problem gambling measures |
|
| ||||||
|
| Australia | 23,479 | Male: | Adults | General population | SOGS, CPGI, VGS |
|
| Greece | 2,141 | Male: 45.4% | Adolescents | General population | DSM-IV |
|
| Spain, Greece, The Netherlands, Poland, Romania, Germany, Iceland | 13,284 | Male: | Adolescents | General population | SOGS |
|
| Thailand | 4,727 | Male: 36% | Adults | General population | DSM-IV |
|
| France | 8,805 | Male: 48.2% | Adolescents, Adults, Older Adults | General population | PGSI |
|
| USA | 43,093 | Only reported for participants with GD | Adults | General population | AUDADIS-IV |
|
| Switzerland | 8,385 | Male: 48% | Adults | General population | NODS |
|
| Finland | 2,826 | Male: | Adolescents, Adults | General population | PGSI |
|
| Finland | 13,721 | Male: | Adolescents, Adults, Older Adults | General population | SOGS |
|
| Chinese in USA | 192 | Male: | Adolescents | General population | SOGS |
|
| Greece | 7,818 | Male NPG: 46.7% | Adults | General and clinical sample | PGSI |
|
| Sweden | 4,358 | Male: | Adolescents, Adults | General population | PGSI, SOGS |
|
| Germany | 9,309 | Male: | Adolescents | General population | DSM-IV |
|
| Italy | 5,920 | Male: 62.3% | Adolescents | General population | SOGS |
|
| Canada | 5,666 | N/A | Adolescents, Young Adults | General population | CPGI |
|
| Romania | 1,032 | Male: 65.57% | Adolescents | General population | 20-GA |
|
| Wales | 37,363 | Male: | Adolescents | General population | N/A |
|
| Japan | 6,576 | Male: | Adults | General population | SOGS |
|
| Finland | 2,984 | Male: | Adults | General population | DSM-IV |
|
| USA | 149 | Male: | Adults | Clinical sample (treatment seeking PGs) | SOGS |
|
| USA | 42,898 | Male: 47.8% | Adults | General population | AUDADIS-IV |
|
| Sweden | 3,191 | Male: | Adolescents, Adults, Older Adults | General population | PGSI |
|
| Canada | 2,187 | Male: | Older Adults | General population | CPGI |
|
| USA | 5,594 | Male: | Adults | General population | SOGS |
|
| South Korea | 8,330 | N/A | Adults | General population | CPGI, NODS, PPGM |
|
| Macao | 1,018 | Male: | Adults | General population | DSM-IV |
|
| ||||||
|
| Spain | 6,816 | Male: 48.4% | Adults, Older Adults | General population | NODS |
|
| Finland | 3,555 | Male: 53.8% | Adults, Older Adults | General population | PGSI |
|
| Canada | 10,035 | Male: | Adolescents | General population | GPSS of the CAGI |
|
| Island of Kos | 2017 | Male: 51.8% | Adolescents | General population | DSM-IV |
|
| Australia | 15,006 | Male: 47.5% | Adults, Older Adults | General population | PGSI |
|
| Spain | 3,772 | Male: 49.8% | Adolescents | General population | N/A |
|
| GB | 9,003 | N/A | Adolescents, Adults | General population | DSM-IV |
|
| Poland | 2000 | Male: 48.2% | Adults | General population | BBGS |
|
| UK | 975 | Male: | Adults | General population | PGSI |
|
| China | 952 community sample (CS) | CS: Male: 42%, Female: 58% | CS: Adults | General population | DSM-IV |
|
| Austria | 3,043 | Only reported for participants with GD | Only reported for participants with GD | General population | Johnson's Lie-and-Bet Questionnaire (Johnson et al., 1997) |
|
| ||||||
|
| Italy | 605 | Male: 38% | Adolescents, Adults | General population | NODS, GAS |
|
| USA | 105 | Only male | Adults | Clinical sample | DSM-IV |
|
| Canada | 19,299 | Male: | Young Adults | General population | DSM-5 |
|
| ||||||
|
| USA | 43,093 | Only reported for participants with GD | Adults | General population | AUDADIS-IV |
|
| France | 25,646 | Male: | Adolescents, Adults, Older Adults | General population | CPGI |
|
| France | 25,646 | Male: | Adolescents, Adults, Older Adults | General population | CPGI |
|
| Finland | 3,251 | Male: | Adolescents, Adults, Older Adults | General population | SOGS |
|
| Spain | 286 | Male: 50% | Adults | Clinical sample | SOGS, DSM-IV |
|
| USA | 501 | Male: | Adults | Clinical sample | SCI-PG, CGI, PG-YBOGS, GSAS |
|
| France | 194 | Male: 82.47% | Adults | Clinical sample | DSM-IV, GRCS |
|
| Australia | 8,917 | Male: | Adults | General population | PGSI |
|
| Spain | 512 | Male: | Adults | Clinical sample | DSM, GRSC |
|
| UK | 1,178 | Male: 92.5% | Adults | Clinical sample | PGSI |
|
| Germany | 200 | Male: 50% | Adults | Clinical sample | ICD-10 |
|
| ||||||
|
| France | 25,647 | Male: | Adolescents, Adults, Older Adults | General population | CPGI |
|
| Chinese in Hong Kong | 4,480 | Male: | Adults | Clinical sample | N/A |
|
| Australia/Spain | 1,092 | Australian Male: 79.3%, Female: 20.7% | Adults | General population | PGSI |
|
| China | 855 | Male: 48.1% | Adults, Older Adults | latent class analysis | DSM-5 |
|
| USA | 2,670 | Male: 51.1% | Adults, Older Adults | Clinical sample | N/A |
|
| N/A | 440 | Male: 54.9% | Adults | Clinical sample | PG-YBOGS, CGI |
|
| US | 2,417 | Male: | Adults | General population | NODS |
|
| UK | 1,178 | Male: 92.5% | Adults | Clinical sample | PGSI |
|
| Canada | 3,604 | N/A | Adults | General population | PGSI |
|
| Australia | 1,172 people weighted to 97,525 to represent the resident Northern Territory adult population who had gambled in the previous 12 months | Male: 52.4% | Adults | General population | N/A |
|
| Sweden | 3,191 | Male: | Adolescents, Adults, Older Adults | General population | PGSI |
|
| Canada | 60 | Male: | Adults | Clinical sample | CPGI |
|
| Canada | 2,187 | Male: | Older Adults | General population | CPGI |
|
| South Korea | 8,330 | N/A | Adults | General population | CPGI, NODS, PPGM |
|
| ||||||
|
| New Zealand | 104 | Male: | Older Adults | General population | N/A |
|
| New Zealand | 209 | Male: | Younger Adults, Older Adults | General population | DSM-IV |
|
| Spain | 103 | Male: | Adults | Clinical sample | DSM-IV |
|
| Australia | 4,945 | N/A | Adults | General population | PGSI |
|
| N/A | 131 | Male: 40% | Adults, Older Adults | Clinical sample (treatment seeking PGs) | SOGS, GAF, CGI, DSM-IV |
|
| Australia | 8,917 | Male: | Adults | General population | PGSI |
|
| UK | 975 | Male: | Adults | General population | PGSI |
|
| Sweden | 257 | Male: | Adults | General population | NODS-PERC, Johnson 's Lie-and-Bet Questionnaire (Johnson et al., 1997) |
|
| Canada | 400 | N/A | Adults | General population | N/A |
|
| ||||||
|
| Spain | 286 | Male: 50% | Adults | Clinical sample | SOGS, DSM-IV |
|
| N/A | 574 | Male: 54% | Adults | Clinical sample | CGI, SCI-GD, PG-YBOGS, GSAS |
|
| USA | 501 | Male: | Adults | Clinical sample | SCI-PG, CGI, PG-YBOGS, GSAS |
|
| Sweden | 327 | Male: | Adults | Clinical sample | PGSI |
|
| Spain | 1,632 | Male: 91.5% | Adults | Clinical sample | SOGS |
|
| Spain | 512 | Male: | Adults | Clinical sample | DSM, GRSC |
|
| New Zealand | 150 | Male: | Adults | Clinical sample | PGSI |
|
| UK | 1,178 | Male: 92.5% | Adults | Clinical sample | PGSI |
|
| ||||||
|
| Brazil | 118 | Only reported for subgroups | Adolescents, Adults | Clinical sample | NODS, DSM-IV |
|
| Canada | 679 | Male: 48.2% | Young adults | General population | PGSI |
|
| N/A | 71 | Male: 52.1% | Adults | Clinical sample | SCI-PG |
|
| Australia | 267 | Male: 54% | Adults | Clinical sample | PGSI |
|
| USA | 2,256 | Male: | Adults | Clinical sample | DSM-IV |
|
| Australia | 4,663 | Male: | Adults | General population | DSM-IV |
|
| ||||||
|
| Germany | 773 | Male: | Adolescents, Adults | Clinical sample (treatment seeking PGs, relatives) | N/A |
|
| Germany | 7,718 | Male: 83.9% | Adults | Clinical and general sample | DSM |
|
| Germany | N/A | N/A | N/A | Clinical sample | ICD-10 |
|
| Spain | 103 | Male: | Adults | Clinical sample | DSM-IV |
|
| USA | 880 | Only reported for subgroups | Adults | Clinical sample (treatment seeking PGs) | MIDI, SCI-PG, PG-YBOCS |
|
| New Zealand | 150 | Male: | Adults | Clinical sample | PGSI |
|
| Canada | 207 | Male: | Adults | Clinical sample | PGSI |
|
| USA | 2,256 | Male: | Adults | Clinical sample | DSM-IV |
|
| ||||||
|
| Germany | 164 | Male: 74.4% | Adults | Clinical sample | CIDI |
|
| Germany | 442 | Male: 83.9% | Adults | Clinical sample | CIDI |
|
| USA | 43,093 | Only reported for participants with GD | Adults | General population | AUDADIS-IV |
|
| France | 25,647 | Male: | Adults, Older Adults | General population | CPGI |
|
| Canada | 354 | Only female | Adults | General population | SOGS |
|
| USA | 591 | Male: | Adults | Clinical sample | ICD-9 |
|
| Israel | 78 | Male: | Adults | Clinical sample | DSM-IV |
|
| Australia | 3,785 | Male: | Adults | General population | NODS |
|
| USA | 43,039 | Male: | Adults | General population | AUDADIS-IV |
|
| Spain | 96 | Male: | Adults | Clinical sample | DSM-IV |
|
| Spain | 103 | Male: | Adults | Clinical sample | DSM-IV |
|
| Spain | 206 | Male: | Adults | Clinical and general population | SCI-PG, SCID-I |
|
| Canada | 5,313 | Male: | Adolescents, Young Adults | General population | DSM-IV, GAQ |
|
| Sweden | 19,016 | Male: | Adolescents, Young Adults | General population | N/A |
|
| Sweden | 327 | Male: | Adults | Clinical sample | PGSI |
|
| Sweden | 106 | Male: | Adults | Clinical sample | DSM-5, ICD-10 |
|
| Sweden | 2099 | Male: 77% | Adults | Clinical sample | ICD-10 |
|
| Spain | 498 | Male: | Adults | Clinical sample | SOGS, DSM-IV |
|
| Sweden | 2099 | Male: | Adults, Older Adults | Clinical sample | DSM-5, ICD-10 |
|
| Canada | 150 | Male: | Adults | Clinical sample | NODS |
|
| USA | 678 | Male: 50% | Young Adults | General population | SOGS |
|
| Scotland | 1827 | Male: | Young Adults | General population | SOGS |
|
| UK | 1,178 | Male: 92.5% | Adults | Clinical sample | PGSI |
|
| Canada | 624 | Male: 47.8% | Young Adults | General population | PGSI |
|
| Sweden | 2010 | Male: 66/65% | N/A | Clinical sample and general population | SOGS, PGSI |
|
| Australia | 212 | Male: | Adults | Clinical sample | PGSI |
|
| Germany | 200 | Male: | Adults | Clinical sample | ICD-10 |
|
| ||||||
|
| Canada | 354 | Only female | Adults | General population | SOGS |
|
| Canada | 1,372 | Male: | Adults, Older Adults | General population | PGSI, CIDI |
|
| USA | 111 | Male: 91.9% | Adults | Clinical sample | GSRI, ASI |
|
| Canada | 150 | Male: | Adults | General population (TN with PG background) | NODS, SOGS |
|
| North America | 149 | Male: | Adults | Clinical sample (treatment seeking PGs) | NODS |
|
| USA | 149 | Male: | Adults | Clinical sample (treatment seeking PGs) | SOGS |
|
| UK | 3,025 | Only male | Adults | General population | SOGS |
|
| USA | 1,675 | Only male | Adults, Older Adults | General population (twins) | DSM-IV |
|
| USA | Cases: 94 | Only reported for subgroups | Adults | General population | SOGS, NODS |
|
| ||||||
|
| USA | 3,334 | Only reported for subgroups | Adults | general population | DSM-IV |
|
| N/A | 86 | Male: | Adults | Clinical sample | SCID-I, SCID-II, SOGS |
|
| USA | 926 | Only female | Adults | General population | N/A |
|
| Australia | 704 | Male: | Adults | Clinial sample (treatment seekingPG | BBGS |
|
| Australia | 4,153 | Male: 48.7% | Adults | General popualtion | PGSI |
|
| Australia | 1,109 | Male: 62.4% | Adults, Older Adults | General population | PGSI |
|
| Spain | 103 | Male: | Adults | Clinical sample | DSM-IV |
|
| Spain | 206 | Male: | Adults | Clinical and general population | SCI-PG, SCID-I |
|
| Sweden | 19,016 | Male: | Adolescents, Young Adults | General population | N/A |
|
| USA | 111 | Male: 91.9% | Adults | Clinical sample | GSRI, ASI |
|
| Canada | 248 | Male: 82.7% | Adults | General population | CPGI |
|
| USA | 515 | Male: | Adolescents | General population | SOGS |
|
| UK | 3,025 | Only male | Adults | General population | SOGS |
|
| Australia | 212 | Male: 49% | Adults | Clinical sample with family members | N/A |
|
| Germany | 200 | Male: 50% | Adults | Clinical sample | ICD-10 |
|
| ||||||
|
| New Zealand | 94 | Only female | Adults | Prisoners | SOGS |
|
| Spain | 2,309 | Male: 88.2% | Adults | Clinical sample | DSM-IV, SOGS |
|
| N/A | 231 | Male: | Adults | Clinical sample | SOGS, ASI-G |
|
| Spain | 273 | Only female | Adults | Clinial sample (treatment seekingPGs) | DSM-IV-TR, SOGS |
|
| Germany | 200 | Male: 50% | Adults | Clinical sample | ICD-10 |
Note.
20-GA The 20 questions of the Gamblers Anonymous American Association.
ASI Addiction Severity Index.
ASI-G Addiction Severity Index Gambling Scale.
AUDADIS-IV Alcohol Use Disorder and Associated Disabilities Interview Schedule – DSM-IV version.
BBGS Brief Biosocial Gambling Screen.
CGI Clinical Global Impression-Severity scale.
CIDI Composite International Diagnostic Interview.
CPGI Canadian problem gambling index.
DSM-IV Pathological gambling diagnosed using the Diagnostic and Statistical Manual of Mental Disorders, 4th edition.
DSM-5 Pathological gambling diagnosed using the Diagnostic and Statistical Manual of Mental Disorders, 5th edition.
GAF Global Assessment of Functioning.
GAQ Gambling Activities Questionnaire.
GAS Gaming Addiction Scale.
GPSS of CAGI Gambling Problem Severity Subscale of the Canadian Adolescent Gambling Inventory.
GRSC Gambling Related Cognitions Scale.
GSAS Gambling Symptom Assessment Scale.
GSRI Gambler's Self-Report Inventory.
ICD-9 Pathological gambling diagnosed using the International Classification of Diseases and related Health Problems, 9th revision.
ICD-10 Pathological gambling diagnosed using the International Classification of Diseases and related Health Problems, 10th revision.
MIDI Minnesota Impulsive Disorders Interview.
NODS National Opinion Research Center (NORC) DSM Screen for Gambling Problems.
NODS-PERC National Opinion Research Center DSM-IV Screen for Gambling Problems - Preoccupation, Escape, Risked relationships and Chasing losses.
PGSI Problem Gambling Severity Index.
PG-YBOGS Pathological Gambling-Modification of the Yale-Brown Obsessive-Compulsive Scale.
PPGM problem and pathological gambling measure.
SCID-I Structured Clinical Interview for DSM IV Axis I Disorders.
SCID-II Structured Clinical Interview for DSM IV Axis II Personality Disorders.
SCI-GD Structured Clinical Interview for Gambling Disorder.
SCI-PG Structured Clinical Interview for Pathological Gambling.
SOGS South Oaks Gambling Screen.
VGS Victorian Gambling Screen.